Detalhe da pesquisa
1.
The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study.
Int J Cancer
; 154(4): 692-700, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37818966
2.
Psychological state and predictors of psychiatric morbidity in COVID-19 patients six weeks after discharge.
Arch Psychiatr Nurs
; 46: 14-20, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37813498
3.
Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
Nutr Cancer
; 73(2): 230-238, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32270713
4.
Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastases.
Future Oncol
; 17(13): 1611-1624, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33631986
5.
Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study.
J Oncol Pharm Pract
; 27(3): 541-546, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32419618
6.
How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.
J Oncol Pharm Pract
; 26(4): 1011-1018, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31615346
7.
Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?
World J Surg Oncol
; 18(1): 242, 2020 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32907593
8.
Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less.
Anticancer Drugs
; 28(2): 222-229, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27768606
9.
Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer.
J BUON
; 22(5): 1191-1198, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29135102
10.
Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology.
Tumour Biol
; 37(4): 5231-7, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553363
11.
Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology.
Tumour Biol
; 37(9): 12033-12038, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27173124
12.
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
J Cancer Res Clin Oncol
; 149(11): 8243-8253, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067546
13.
Psychological impacts of COVID-19 pandemic in cancer patients on active treatment.
Heliyon
; 8(8): e10142, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35996550
14.
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group.
J Cancer Res Ther
; 18(12 Suppl 2): S347-S353, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36510987
15.
Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer.
Sci Rep
; 11(1): 14131, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34239026
16.
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study.
J Cancer Res Clin Oncol
; 147(7): 2145-2152, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33433657
17.
Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy.
Clin Breast Cancer
; 20(4): 332-343.e3, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32201164
18.
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.
J BUON
; 25(2): 641-647, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32521847
19.
Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy.
J BUON
; 24(4): 1494-1500, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31646797
20.
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.
J BUON
; 24(5): 1876-1883, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31786850